Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Home-use microneedle devices might safely boost 5% minoxidil's effectiveness for hair growth.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Topical valproate can effectively promote hair growth.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Hair growth is cyclic and influenced mainly by local factors.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Corporate social responsibility can improve consumer ratings of product performance, especially when the company is seen as benevolent and consumers aren't experts on the product.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

5% minoxidil works better for hair growth and density, with minor irritation.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.